Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atenolol for Functional Recovery in Elderly Surgery
NCT00507663Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Sep 2002
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atenolol in Post-operative cognitive dysfunction (POCD), functional decline, sponsored by Icahn School of Medicine at Mount Sinai. Started Sep 2002; status: completed.
02
Drugs
atenolol
03
Conditions
Post-operative cognitive dysfunction (POCD)functional decline
Beyond the preview
Go deeper on NCT00507663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00507663.